Impact of esketamine intravenous analgesic pump on pain and depression post-cesarean
The use of the Esketamine Intravenous Analgesic Pump significantly reduces postoperative pain and the incidence of postpartum depression within the first 14 days. It promotes early recovery and breastfeeding in postpartum women without significant adverse reactions, making it a valuable addition to postoperative care.
Authors
- Xiaolin Qin (ORCID: https://orcid.org/0000-0002-8845-1089)
- Xiaoqiang Zhang (ORCID: https://orcid.org/0000-0001-5340-7697)
- Shuang Li (ORCID: https://orcid.org/0000-0002-3483-5087)
Institutions
- Jingning County People's Hospital (CN)
Publication Details
- Journal
- BMC Surgery
- Published
- 2025-04-08
- DOI
- https://doi.org/10.1186/s12893-025-02868-y
- Primary Topic
- Anesthesia and Pain Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- CIEE Ping Foundation